XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock [Member]
TreasuryStockMember
Capital in excess of stated value [Member]
Retained Earnings [Member]
Accumulated other comprehensive income (loss) [Member]
Beginning balance at Mar. 31, 2022 $ 97,344 $ 9,482 $ (2,063) $ 49,963 $ 40,018 $ (56)
Beginning balance (in shares) at Mar. 31, 2022   31,607 (6,879)      
Share-based compensation 6,019     6,019    
Restricted shares issued, net     $ 73 (73)    
Restricted shares issued, net (in shares)     245      
Shares issued upon exercise of SSARs     $ 37 (37)    
Shares issued upon exercise of SSARs ( in shares)     123      
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (1,812)   $ (12) (1,800)    
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)     (39)      
Net Income (Loss) 6,615       6,615  
Series A convertible preferred stock dividends (918)       (918)  
Unrealized translation adjustments (654)         (654)
Ending balance at Sep. 30, 2022 106,594 $ 9,482 $ (1,965) 54,072 45,715 (710)
Ending balance (in shares) at Sep. 30, 2022   31,607 (6,550)      
Beginning balance at Jun. 30, 2022 101,276 $ 9,482 $ (1,974) 51,624 42,598 (454)
Beginning balance (in shares) at Jun. 30, 2022   31,607 (6,582)      
Share-based compensation 3,396     3,396    
Restricted shares issued, net     $ (2) 2    
Restricted shares issued, net (in shares)     (5)      
Shares issued upon exercise of SSARs     $ 16 (16)    
Shares issued upon exercise of SSARs ( in shares)     54      
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (939)   $ (5) (934)    
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)     (17)      
Net Income (Loss) 3,576       3,576  
Series A convertible preferred stock dividends (459)       (459)  
Unrealized translation adjustments (256)         (256)
Ending balance at Sep. 30, 2022 106,594 $ 9,482 $ (1,965) 54,072 45,715 (710)
Ending balance (in shares) at Sep. 30, 2022   31,607 (6,550)      
Beginning balance at Mar. 31, 2023 109,310 $ 9,482 $ (1,884) 52,978 52,764 (4,030)
Beginning balance (in shares) at Mar. 31, 2023   31,607 (6,280)      
Share-based compensation 5,911     5,911    
Restricted shares issued, net     $ 1 (1)    
Restricted shares issued, net (in shares)     4      
Shares issued upon exercise of SSARs     $ 27 (27)    
Shares issued upon exercise of SSARs ( in shares)     90      
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (3,722)   $ (15) (3,707)    
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)     (50)      
Net Income (Loss) 6,093       6,093  
Series A convertible preferred stock dividends (918)       (918)  
Unrealized translation adjustments (56)         (56)
Ending balance at Sep. 30, 2023 116,618 $ 9,482 $ (1,871) 55,154 57,939 (4,086)
Ending balance (in shares) at Sep. 30, 2023   31,607 (6,236)      
Beginning balance at Jun. 30, 2023 111,686 $ 9,482 $ (1,877) 53,735 53,853 (3,507)
Beginning balance (in shares) at Jun. 30, 2023   31,607 (6,255)      
Share-based compensation 2,534     2,534    
Restricted shares issued, net     $ (2) 2    
Restricted shares issued, net (in shares)     (8)      
Shares issued upon exercise of SSARs     $ 12 (12)    
Shares issued upon exercise of SSARs ( in shares)     40      
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (1,109)   $ (4) (1,105)    
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)     (13)      
Net Income (Loss) 4,545       4,545  
Series A convertible preferred stock dividends (459)       (459)  
Unrealized translation adjustments (579)         (579)
Ending balance at Sep. 30, 2023 $ 116,618 $ 9,482 $ (1,871) $ 55,154 $ 57,939 $ (4,086)
Ending balance (in shares) at Sep. 30, 2023   31,607 (6,236)